Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia.
暂无分享,去创建一个
E. Tangalos | R. Petersen | H. Braak | R. Ivnik | B. Boeve | D. Knopman | G. Jicha | D. Dickson | J. Parisi | R. Cha | Kris A. Johnson | K. Johnson | D. Knopman
[1] Peter Davies,et al. Identification of normal and pathological aging in prospectively studied nondemented elderly humans , 1992, Neurobiology of Aging.
[2] E. Tangalos,et al. CME Practice parameter: , 2022 .
[3] J. Cummings,et al. Alzheimer's disease and related disorders annual , 2000 .
[4] D. Schaid,et al. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. , 1995, JAMA.
[5] W. Markesbery,et al. Cerebrovascular Pathology and Dementia in Autopsied Honolulu‐Asia Aging Study Participants , 2002, Annals of the New York Academy of Sciences.
[6] D. Bennett,et al. Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment. , 1999, Experimental neurology.
[7] F. Schmitt,et al. Alzheimer neuropathologic alterations in aged cognitively normal subjects. , 1999, Journal of neuropathology and experimental neurology.
[8] B. Winblad,et al. Clinical trials in mild cognitive impairment: lessons for the future , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[9] John Q. Trojanowski,et al. Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease , 1997, Neurobiology of Aging.
[10] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[11] W. Markesbery,et al. Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: Findings from the Nun Study , 2002, Annals of neurology.
[12] C. Jack,et al. Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment , 2004, Journal of internal medicine.
[13] J. Morris,et al. Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage alzheimer’s disease , 2001, Journal of Molecular Neuroscience.
[14] J. Morris. The Clinical Dementia Rating (CDR) , 1993, Neurology.
[15] H. Braak,et al. CORTICAL AND SUBCORTICAL ARGYROPHILIC GRAINS CHARACTERIZE A DISEASE ASSOCIATED WITH ADULT ONSET DEMENTIA , 1989, Neuropathology and applied neurobiology.
[16] D. Mash,et al. Neuropathological and neuropsychological changes in "normal" aging: evidence for preclinical Alzheimer disease in cognitively normal individuals. , 1998, Journal of neuropathology and experimental neurology.
[17] Linda Teri,et al. Clinico‐Neuropathological Correlation of Alzheimer's Disease in a Community‐Based Case Series , 1999, Journal of the American Geriatrics Society.
[18] J. Schneider,et al. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions , 2005, Neurology.
[19] Keith A. Johnson,et al. Neuropathology of Cognitively Normal Elderly , 2003, Journal of neuropathology and experimental neurology.
[20] B. Reisberg,et al. The Global Deterioration Scale for assessment of primary degenerative dementia. , 1982, The American journal of psychiatry.
[21] E. Tangalos,et al. Mayo Clinic Alzheimer’s Disease Patient Registry , 1990, Aging.
[22] J. Schneider,et al. Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease , 2002, Annals of neurology.
[23] D. Dickson,et al. Selective Neurofibrillary Degeneration of the Hippocampal CA2 Sector Is Associated with Four‐Repeat Tauopathies , 2002, Journal of neuropathology and experimental neurology.
[24] S. Wisniewski,et al. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment , 2002, Annals of neurology.
[25] S. M. Sumi,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.
[26] H. Amièva,et al. Incidence and outcome of mild cognitive impairment in a population-based prospective cohort , 2002, Neurology.
[27] M. Mesulam,et al. Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. , 2003, Archives of neurology.
[28] D. A. Bennett,et al. Natural history of mild cognitive impairment in older persons , 2002, Neurology.
[29] E. Tangalos,et al. Neuropathologic features of amnestic mild cognitive impairment. , 2006, Archives of neurology.
[30] S. Murayama,et al. Staging of Argyrophilic Grains: An Age‐Associated Tauopathy , 2004, Journal of neuropathology and experimental neurology.
[31] L. Beckett,et al. Entorhinal Cortex β-Amyloid Load in Individuals with Mild Cognitive Impairment , 1999, Experimental Neurology.
[32] Mrc Psych,et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop , 1996 .
[33] S. M. Sumi,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology Confirmation of the Clinical Diagnosis of Alzheimer's Disease , 1995, Neurology.
[34] R. Petersen. Mild cognitive impairment as a diagnostic entity , 2004, Journal of internal medicine.
[35] E. Tangalos,et al. Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .
[36] R. Schiffer,et al. Incorrect diagnosis of Alzheimer's disease. A clinicopathologic study. , 1996, Archives of neurology.
[37] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[38] D. Dickson,et al. Increased Frequency of Argyrophilic Grain Disease in Alzheimer Disease with 4R Tau-Specific Immunohistochemistry , 2005, Journal of neuropathology and experimental neurology.
[39] Z. Khachaturian. Diagnosis of Alzheimer's disease. , 1985, Archives of neurology.
[40] K. Jellinger,et al. Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study. , 2002, Neurology.
[41] D. Bennett,et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. , 2005, The New England journal of medicine.
[42] K P Offord,et al. A short test of mental status: description and preliminary results. , 1987, Mayo Clinic proceedings.
[43] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[44] K. Davis,et al. Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease. , 1998, Archives of neurology.
[45] S. Salloway,et al. Efficacy of donepezil in mild cognitive impairment , 2004, Neurology.